Nevertheless, our analysis is based on a relatively small sample size and so further validation on a large cohort will be required to fully assess the potential of ADAT2 as a marker of BRCA1 deficiency. This evidence concerns the gene ADAT2 and hyperinsulinemic hypoglycemia, familial, 4.